<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-11-05</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39497458/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Detection of suicidality from medical text using privacy-preserving large language models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39497458-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The study demonstrates the capability of LLMs, particularly Llama-2, in accurately extracting information on suicidality from psychiatric records while preserving data privacy. This suggests their application in surveillance systems for psychiatric emergencies and improving the clinical management of suicidality by improving systematic quality control and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39497685/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Evaluating the effectiveness of the &#39;eco-cooler&#39; for passive home cooling</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39497685-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Constructed with used plastic bottles, the eco-cooler has been widely adopted in resource-poor communities in Bangladesh and other countries. We tested the eco-cooler under controlled conditions using a scientific wind tunnel in a climatic chamber. In our tests, we used seven eco-cooler designs in 27 climate conditions typical of Bangladesh (temperatures of 40 ¬∞C, 35 ¬∞C, and 30 ¬∞C; humidity levels of 70%, 60%, and 40%; and wind speeds of 4.0 m s^(-1), 2.0 m s^(-1), and 0.2 m s^(-1)) in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39498278/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Search for Pauli Exclusion Principle violations with Gator at LNGS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39498278-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Pauli Exclusion Principle (PEP) appears from fundamental symmetries in quantum field theories, but its physical origin is still to be understood. High-precision experimental searches for small PEP violations permit testing key assumptions of the Standard Model with high sensitivity. We report on a dedicated measurement with Gator, a low-background, high-purity germanium detector operated at the Laboratori Nazionali del Gran Sasso, aimed at testing PEP-violating atomic transitions in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39498498/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Sci-ModoM: a quantitative database of transcriptome-wide high-throughput RNA modification sites</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39498498-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We present Sci-ModoM, the first next-generation RNome database offering a holistic view of the epitranscriptomic landscape. Sci-ModoM has a simple yet powerful interface, underpinned by FAIR data principles, a standardized nomenclature, and interoperable formats, fostering the use of common standards within the epitranscriptomics community. Sci-ModoM provides quantitative measurements per site and dataset, enabling users to assess confidence levels based on score, coverage, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39499134/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">A Novel Artificial Endothelial Replacement Membrane for the Treatment of Chronic Corneal Edema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39499134-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The first-in-human results of EndoArt implantation demonstrated the device&rsquo;s potential to treat patients suffering from corneal edema with a favorable safety profile and effective edema reduction in most subjects, with no device-related serious adverse event. The EndoArt may offer a viable solution in regions facing a shortage of donor corneas, as well as for patients who have poor prognosis with human &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39499209/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39499209-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39499362/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Definition and Predictors of Early Recurrence in Neoadjuvantly Treated Esophageal and Gastroesophageal Adenocarcinoma: a Dual-Center Retrospective Cohort Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39499362-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Early recurrence can be defined as recurrent disease within 18 months. Hallmarks for early recurrence are poor response to neoadjuvant therapy with persisting advanced disease. In those patients, adjuvant therapy and closer follow-up should be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39499491/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Mitochondrial respiratory pathways in immature rat heart tissue using different cardioplegic solutions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39499491-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Del Nido cardioplegic solution provided optimal mitochondrial protection under moderate and long myocardial ischemia &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39490993/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Expected benefits and concerns regarding virtual reality in caring for terminally ill cancer patients - a qualitative interview study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39490993-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: VR seems to be of interest for palliative cancer patients, especially as distraction and relief from their illness. The desired content can be very different, so a choice from a selection of VR-content should be made available. If patients want to see videos of their own home, recordings by relatives instead of study or hospital staff seem to meet the need for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39491308/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Local cellular interactions during the self-organization of stem cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39491308-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Stem cell models for early mammalian development offer new experimental opportunities to access spatio-temporal details of the cell-cell interactions that govern cell differentiation and tissue patterning. This review summarizes recent studies that have used stem cell models to investigate the spatial range of developmental cell-cell communication systems. A key message from these works is that important biochemical signals for cell differentiation in these systems, such as Nodal and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39491482/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">A Prospective, Multicenter European Study on the Effects of Anatolian Propolis and Hypertonic Saline Combination Nasal Spray on Allergic Rhinitis Symptoms</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39491482-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objectives: The current study examined the effectiveness of Rhinapi, a hypertonic saline nasal spray with Anatolian propolis added, on allergic rhinitis (AR) symptoms in a European population. Methods: Four hundred and forty AR patients (251 males and 189 females) from various European centers were enrolled. Nasal examination, overall symptom scores, individual AR symptoms (nasal discharge, sneezing, nasal itching, and nasal obstruction), and quality of life (QoL) were assessed before and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39491638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Atlas of gray matter volume differences across psychiatric conditions: A systematic review with a novel meta-analysis that considers co-occurring disorders</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39491638-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This work offers the most comprehensive atlas of GMV correlates across major mental disorders. Modeling co-occurring disorders yielded more specific correlates, supporting this approach&rsquo;s validity. The atlas NIfTI maps are available &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39491874/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Depression symptoms, wellbeing, health-related quality of life, and diabetes-related distress in novel subtypes of recent-onset diabetes in Germany: a 5-year observational follow-up study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39491874-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: The subjective experiences of individuals living with diabetes is commonly assessed with patient-reported outcomes (PROs; eg, depression symptoms, wellbeing, health-related quality of life [HRQOL], and diabetes-related distress). Cluster analyses have identified novel diabetes subtypes differing in phenotypic and metabolic characteristics. We aimed to investigate associations between these subtypes and PROs and whether subtype predicted PROs 5 years &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39491878/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Sex-sensitive and gender-sensitive care for patients with mental disorders</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39491878-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39492291/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Response to letter: Re: Observational study investigating the level of support from a convolutional neural network in face and scalp lesions deemed diagnostically &#39;unclear&#39; by dermatologists</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39492291-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39492632/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Genomic Vulnerability to Climate Change of an Australian Migratory Freshwater Fish, the Golden Perch (Macquaria ambigua)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39492632-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Genomic vulnerability is a measure of how much evolutionary change is required for a population to maintain optimal genotype-environment associations under projected climates. Aquatic species, and in particular migratory ectotherms, are largely underrepresented in studies of genomic vulnerability. Such species might be well equipped for tracking suitable habitat and spreading diversity that could promote adaptation to future climates. We characterised range-wide genomic diversity and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39493721/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Exploring the association between phytopharmaceutical use and antibiotic prescriptions in upper respiratory infections: results from a German cohort study evaluating the impact of naturopathy qualifications of general practitioners using routine data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39493721-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Prescriptions of phytopharmaceuticals were significantly associated with a decrease antibiotic prescriptions among GPs, especially when combined with naturopathy qualifications. Training in naturopathic approaches could enhance antibiotic stewardship efforts in primary care settings, suggesting that broader integration of CIM elements into medical training could be beneficial in mitigating antibiotic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39493903/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Party preferences for climate policy and the renewable energy transition in Spain&#39;s multilevel democracy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39493903-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The growing influence of regional governments in shaping climate policy and driving the renewable energy transition in multilevel democracies like Spain provides incentives for parties in favor of decentralization to emphasize these issues. Recent research has shown that such parties act as climate pioneers at the regional tier of government, driven by their desire to assert stronger subnational authority. To investigate these dynamics at the national level, this article examines the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494352/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494352-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Soluble guanylate cyclase (sGC) stimulators and activators are known to enhance kidney function in various models of chronic kidney disease (CKD) by increasing cyclic guanosine monophosphate (cGMP). Their differential effects on CKD progression, particularly under conditions of oxidative stress, remain unexplored by direct comparative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494352/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494352-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Soluble guanylate cyclase (sGC) stimulators and activators are known to enhance kidney function in various models of chronic kidney disease (CKD) by increasing cyclic guanosine monophosphate (cGMP). Their differential effects on CKD progression, particularly under conditions of oxidative stress, remain unexplored by direct comparative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494808/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241104202143&amp;v=2.18.0.post9&#43;e462414">I Am Nothing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494808-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241104202143-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494808/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241105174549&amp;v=2.18.0.post9&#43;e462414">I Am Nothing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494808-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241105174549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494822/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241104202143&amp;v=2.18.0.post9&#43;e462414">Angiokeratoma of Fordyce</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494822-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241104202143-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494822/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241105174549&amp;v=2.18.0.post9&#43;e462414">Angiokeratoma of Fordyce</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494822-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241105174549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494838/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241104202143&amp;v=2.18.0.post9&#43;e462414">Reframing Cerebral Palsy as a Lifelong Physical Disability</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494838-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241104202143-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39494838/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241105174549&amp;v=2.18.0.post9&#43;e462414">Reframing Cerebral Palsy as a Lifelong Physical Disability</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39494838-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241105174549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Enzymes Repertoires and Genomic Insights into Lycium Barbarum Pectin Polysaccharides Biosynthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lycium barbarum, a member of the Solanaceae family, represents an important eudicot lineage with homology of food and medicine. Lycium barbarum pectin polysaccharides (LBPPs) are key bioactive ingredients of Lycium barbarum, and are among the few polysaccharides with both biocompatibility and biomedical activity. While previous studies have primarily focused on the functional properties of LBPPs, the mechanisms of biosynthesis and transport by key enzymes remain poorly understood. Here, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Enzymes Repertoires and Genomic Insights into Lycium Barbarum Pectin Polysaccharides Biosynthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lycium barbarum, a member of the Solanaceae family, represents an important eudicot lineage with homology of food and medicine. Lycium barbarum pectin polysaccharides (LBPPs) are key bioactive ingredients of Lycium barbarum, and are among the few polysaccharides with both biocompatibility and biomedical activity. While previous studies have primarily focused on the functional properties of LBPPs, the mechanisms of biosynthesis and transport by key enzymes remain poorly understood. Here, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495206/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">FOXR2 targets LHX6&#43;/DLX&#43; neural lineages to drive CNS neuroblastoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495206-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Central nervous system neuroblastoma with FOXR2 activation (NB-FOXR2) is a high-grade tumor of the brain hemispheres and a newly identified molecular entity. Tumors express dual neuronal and glial markers, leading to frequent misdiagnoses, and limited information exists on the role of FOXR2 in their genesis. To identify their cellular origins, we profiled the transcriptomes of NB-FOXR2 tumors at the bulk and single-cell levels and integrated these profiles with large single-cell references &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495206/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">FOXR2 targets LHX6&#43;/DLX&#43; neural lineages to drive CNS neuroblastoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495206-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Central nervous system neuroblastoma with FOXR2 activation (NB-FOXR2) is a high-grade tumor of the brain hemispheres and a newly identified molecular entity. Tumors express dual neuronal and glial markers, leading to frequent misdiagnoses, and limited information exists on the role of FOXR2 in their genesis. To identify their cellular origins, we profiled the transcriptomes of NB-FOXR2 tumors at the bulk and single-cell levels and integrated these profiles with large single-cell references &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495297/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Germline copy number variants and endometrial cancer risk</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495297-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Known risk loci for endometrial cancer explain approximately one third of familial endometrial cancer. However, the association of germline copy number variants (CNVs) with endometrial cancer risk remains relatively unknown. We conducted a genome-wide analysis of rare CNVs overlapping gene regions in 4115 endometrial cancer cases and 17,818 controls to identify functionally relevant variants associated with disease. We identified a 1.22-fold greater number of CNVs in DNA samples from &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495297/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Germline copy number variants and endometrial cancer risk</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495297-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Known risk loci for endometrial cancer explain approximately one third of familial endometrial cancer. However, the association of germline copy number variants (CNVs) with endometrial cancer risk remains relatively unknown. We conducted a genome-wide analysis of rare CNVs overlapping gene regions in 4115 endometrial cancer cases and 17,818 controls to identify functionally relevant variants associated with disease. We identified a 1.22-fold greater number of CNVs in DNA samples from &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495788/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Radiosurgery-induced early changes in peritumoral tissue sodium concentration of brain metastases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495788-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Tissue sodium concentration assessment within brain metastases and peritumoral tissue after SRS with 23Na MRI is feasible and might be able to quantify tissue response to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495788/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Radiosurgery-induced early changes in peritumoral tissue sodium concentration of brain metastases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495788-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Tissue sodium concentration assessment within brain metastases and peritumoral tissue after SRS with 23Na MRI is feasible and might be able to quantify tissue response to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">How to survive enormous amounts of alcohol</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">How to survive enormous amounts of alcohol</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495965/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241104202650&amp;v=2.18.0.post9&#43;e462414">Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE‚Ñ¢-1 and -2)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495965-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241104202650-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: These trials are designed to provide robust evaluation of the efficacy, safety, and tolerability of survodutide for the treatment of obesity in the presence or absence of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39495965/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE‚Ñ¢-1 and -2)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39495965-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: These trials are designed to provide robust evaluation of the efficacy, safety, and tolerability of survodutide for the treatment of obesity in the presence or absence of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39496294/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Position Paper of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) and the German Roentgen Society (DRG) on Structural and Professional Requirements in Interventional Oncology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39496294-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Interventional oncology (IO) employs various techniques to enable minimally invasive, image-guided treatment of tumor diseases with both curative and palliative goals. Additionally, it significantly contributes to managing tumor-related and perioperative complications, offering diverse supportive procedures for patients at all stages of their diseases. The execution of IO procedures places unique demands on the equipment, personnel, and structural organization of radiological &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39496464/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39496464-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Apheresis is frequently used in MOGAD attacks. An early start as first-line therapy and concomitant disease-modifying therapy predict full attack &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39496731/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Histidine containing dipeptides protect epithelial and endothelial cell barriers from methylglyoxal induced injury</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39496731-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Integrity of epithelial and endothelial cell barriers is of critical importance for health, barrier disruption is a hallmark of numerous diseases, of which many are driven by carbonyl stressors such as methylglyoxal (MG). Carnosine and anserine exert some MG-quenching activity, but the impact of these and of other histidine containing dipeptides on cell barrier integrity has not been explored in detail. In human proximal tubular (HK-2) and umbilical vein endothelial (HUVEC) cells, exposure &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39497108/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39497108-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Osteosarcoma is the most common form of primary bone cancer, which primarily afflicts children and adolescents. Chemotherapy, consisting of doxorubicin, cisplatin and methotrexate (MAP) increased the 5-year osteosarcoma survival rate from 20% to approximately 60% by the 1980s. However, osteosarcoma survival rates have remained stagnant for several decades. Patients whose disease fails to respond to MAP receive second-line treatments such as etoposide and, in more recent years, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39497174/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241105174555&amp;v=2.18.0.post9&#43;e462414">Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39497174-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241105174555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: ALE, RRMS, and pCNS-tumors show distinct but partially overlapping changes mainly in HLA-DR^(+) Tc, memory Tc, exhausted Tc, and Bc subsets providing insights into disease pathogenesis. Moreover, mFC shows diagnostic potential facilitating early diagnosis and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pypi.org/project/label-studio/1.14.0/">1.14.0</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/pypi-org-project-label-studio-1-14-0/">
    
    
    
    
    
      
    
    Label Studio annotation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKAXeczp">üîª‚ÄúËøôÈÉΩÊâì‰∏çÊ≠ªÔºü‚Äù ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekaxeczp/">
    
    
    
    
    
      
    
    üîª‚ÄúËøôÈÉΩÊâì‰∏çÊ≠ªÔºü‚Äù <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/Oh5HrLzylx08jkE04Uas01041200FJLo0E010.mp4?label">https://f.video.weibocdn.com/o0/Oh5HrLzylx08jkE04Uas01041200FJLo0E010.mp4?label</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKJiDxjY">üîªË∞∑Ê≠åÂÖ¨Â∏É‰∫ÜÂü∫ËæÖÊú±Âà©‰∫öÂ∞ºÊú∫Âú∫Èò≤Á©∫Á≥ªÁªüÁöÑËØ¶ÁªÜ‰ΩçÁΩÆÔºåÂπ∂Âú®‰∏äÂë®Êú´ÂØπ‰πåÂÖãÂÖ∞ÁöÑÁõ∏ÂÖ≥ËØ∑Ê±ÇÁΩÆ‰πã‰∏çÁêÜ„ÄÇüîªvia vk ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekjidxjy/">
    
    
    
    
    
      
    
    üîªË∞∑Ê≠åÂÖ¨Â∏É‰∫ÜÂü∫ËæÖÊú±Âà©‰∫öÂ∞ºÊú∫Âú∫Èò≤Á©∫Á≥ªÁªüÁöÑËØ¶ÁªÜ‰ΩçÁΩÆÔºåÂπ∂Âú®‰∏äÂë®Êú´ÂØπ‰πåÂÖãÂÖ∞ÁöÑÁõ∏ÂÖ≥ËØ∑Ê±ÇÁΩÆ‰πã‰∏çÁêÜ„ÄÇ<!-- raw HTML omitted -->üîªvia vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.wei">https://f.video.wei</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKMqj8I7">üîªÂõæ1Ëøô‰∏™ÂõæËøô‰∏§Â§©ÂèàÂú®ÂæÆÂçöÊµÅË°åËµ∑Êù•‰∫Ü„ÄÇüîª‰πç‰∏ÄÁúãÂæàÂêì‰∫∫ÔºåÁÆó‰∏Ä‰∏ãÂ∞±Áü•ÈÅìÊå∫Âº±Êô∫ÁöÑ„ÄÇüîª‰∏∫‰ªÄ‰πàËøô‰πàËØ¥ÔºüüîªÂí±‰ª¨Â∞±‰∏çËØ¥Âõæ1Êï∞ÊçÆÁöÑÁúüÂÅáÔºåÂ∞±ÊåâÁÖßÂõæ1ÁöÑÊï∞ÊçÆÔºåÂØπÊØî‰∏Ä...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekmqj8i7/">
    
    
    
    
    
      
    
    üîªÂõæ1Ëøô‰∏™ÂõæËøô‰∏§Â§©ÂèàÂú®ÂæÆÂçöÊµÅË°åËµ∑Êù•‰∫Ü„ÄÇ<!-- raw HTML omitted -->üîª‰πç‰∏ÄÁúãÂæàÂêì‰∫∫ÔºåÁÆó‰∏Ä‰∏ãÂ∞±Áü•ÈÅìÊå∫Âº±Êô∫ÁöÑ„ÄÇ<!-- raw HTML omitted -->üîª‰∏∫‰ªÄ‰πàËøô‰πàËØ¥Ôºü<!-- raw HTML omitted -->üîªÂí±‰ª¨Â∞±‰∏çËØ¥Âõæ1Êï∞ÊçÆÁöÑÁúüÂÅáÔºåÂ∞±ÊåâÁÖßÂõæ1ÁöÑÊï∞ÊçÆÔºåÂØπÊØî‰∏Ä‰∏ãÁæéÂõΩÁöÑÊï∞ÊçÆÂêß„ÄÇ<!-- raw HTML omitted -->üîªÊ†πÊçÆÁæéÂõΩ‰∫∫Âè£ÊôÆÊü•Â±Ä„ÄäÂΩìÂâç‰∫∫Âè£Êä•Âëä„ÄãÔºå2022Âπ¥ÁæéÂõΩ5Â≤Å‰ª•‰∏ãÂ©¥ÂÑøÊï∞ÈáèÊòØ 2240 ‰∏á„ÄÇ<!-- raw HTML omitted -->üîªËÄåÊ†πÊçÆ„Ää2024 Âπ¥ AVMA ÂÆ†Áâ©Êã•ÊúâÈáèÂíå‰∫∫Âè£ÁªüËÆ°ÊâãÂÜå„ÄãÔºàÊï∞ÊçÆÂåπÈÖçÁæéÂõΩ‰∫∫Âè£ÊôÆÊü•Â±ÄÊä•ÂëäÁöÑÁæéÂõΩ‰∫∫Âè£ÂíåÂÆ∂Â∫≠‰ø°ÊÅØ‰∏≠ÁöÑÂàÜÂ∏ÉÔºâÔºå2024Âπ¥ÁæéÂõΩÂÆ∂Â∫≠ÂÖâÊã•ÊúâÁöÑÂÆ†Áâ©ÁãóÂ∞±Êúâ 5980 ‰∏áÔºåÁå´Êúâ 4220 ‰∏á„ÄÇ<!-- raw HTML omitted -->üîªÁæéÂõΩÂÆ∂Â∫≠Êã•ÊúâÁöÑÂÆ†Áâ©Áå´Êï∞ÈáèÊé•ËøëÁæéÂõΩ 5 Â≤Å‰ª•‰∏ãÂ©¥ÂÑøÊï∞ÈáèÁöÑ 2 ÂÄçÔºåËøôËøòÊ≤°ÁÆóÁãóÂë¢ÔºåÊ≤°ÁÆó‰Ωú‰∏∫ÂÆ†Áâ©È•≤ÂÖªÁöÑÈ±º„ÄÅÁà¨Ë°åÂä®Áâ©„ÄÅÈ∏üÁ±ª„ÄÅÂ∞èÂûãÂì∫‰π≥Âä®Áâ©„ÄÅÂÖîÂ≠ê„ÄÅÈ©¨Âåπ„ÄÅÂÆ∂Á¶Ω„ÄÇ<!-- raw HTML omitted -->üîªÁæéÂõΩ‰∫∫ÈÉΩÊ≤°ÁùÄÊÄ•ÔºåÂà∞Â§ÑËΩ¨ÂèëÂõæ1ÁöÑÁùÄ‰ªÄ‰πàÊÄ•Ôºü<!-- raw HTML omitted -->üîªÊÉ≥ÂêìÂî¨Ë∞ÅÔºü&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbly1hvam46yr47j20j606j">https://tvax3.sinaimg.cn/large/639b1bfbly1hvam46yr47j20j606j</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKOA9A5k">üîª‰∏Ä‰∫õÊó•Êú¨‰ªé‰∏ö‰∫∫ÂëòÔºå‰πüÊääÂú®Â§ß‰πÖ‰øùË°óÊãçÂá∫Èïú‰Ωú‰∏∫ÂçñÁÇπ‰∫Ü„ÄÇüîªÂìéÔºåÊó•Êú¨ÁªèÊµé„ÄÇ [ÂõæÁâá][ÂõæÁâá]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekoa9a5k/">
    
    
    
    
    
      
    
    üîª‰∏Ä‰∫õÊó•Êú¨‰ªé‰∏ö‰∫∫ÂëòÔºå‰πüÊääÂú®Â§ß‰πÖ‰øùË°óÊãçÂá∫Èïú‰Ωú‰∏∫ÂçñÁÇπ‰∫Ü„ÄÇ<!-- raw HTML omitted -->üîªÂìéÔºåÊó•Êú¨ÁªèÊµé„ÄÇ <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKPZ4jtA">ÊâÄ‰ª•Ê≤°ÂéªÁöÑÂÅ∑ÁùÄ‰πê„ÄÇÊàëÂ∞±Á≠âÁùÄÂÅ∑Ê¥ûÊ¥ûÁöÑÂõæ„ÄÇ - ËΩ¨Âèë @ÁÇÆÈú∏707ÂÜõÊÉÖÂ∞èÁ´ô:&amp;ensp;‰ªäÂπ¥ÁöÑÁè†Êµ∑Ëà™Â±ïÂìéÔºåÁªÑÁªáÁöÑÁÆÄÁõ¥Â∞±ÊòØÁãóÂ±Å„ÄÇ‰∏ÄÊñπÈù¢ÊòØÊúâÂè≤‰ª•Êù•ÊúÄË¥µÁöÑËà™Â±ïÔºå‰∏ÄÊñπÈù¢Âõ†‰∏∫ÂêÑÁßç...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekpz4jta/">
    
    
    
    
    
      
    
    ÊâÄ‰ª•Ê≤°ÂéªÁöÑÂÅ∑ÁùÄ‰πê„ÄÇÊàëÂ∞±Á≠âÁùÄÂÅ∑Ê¥ûÊ¥ûÁöÑÂõæ„ÄÇ<!-- raw HTML omitted --><!-- raw HTML omitted --> - ËΩ¨Âèë <!-- raw HTML omitted -->@ÁÇÆÈú∏707ÂÜõÊÉÖÂ∞èÁ´ô<!-- raw HTML omitted -->:‚ÄÇ‰ªäÂπ¥ÁöÑÁè†Êµ∑Ëà™Â±ïÂìéÔºåÁªÑÁªáÁöÑÁÆÄÁõ¥Â∞±ÊòØÁãóÂ±Å„ÄÇ‰∏ÄÊñπÈù¢ÊòØÊúâÂè≤‰ª•Êù•ÊúÄË¥µÁöÑËà™Â±ïÔºå‰∏ÄÊñπÈù¢Âõ†‰∏∫ÂêÑÁßçÂ±ïÂìÅÊù•ÂæóÊó©ÔºåÂêÑÁßçÊèêÂâçÂâßÈÄèÊé¢Âú∫‰∏çÊñ≠„ÄÇÁé∞Âú®Áâπ‰πàËøûÂú∫È¶ÜËøõË°åÈ´òÁ©∫‰Ωú‰∏öÁöÑ‰∫∫ÈÉΩÂú®Áõ¥Êí≠‚Ä¶‚Ä¶ÂëµÂëµ„ÄÇ<!-- raw HTML omitted -->Ê≤°ÂéªÁúãËà™Â±ïÔºåÂ∑≤ÁªèÁúã‰∫Ü‰∏™‰∏É‰∏ÉÂÖ´ÂÖ´„ÄÇËøôÁâπ‰πà‰∏çÊòØÊêûÁ¨ë‰πàÔºÅ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKsnepoq">üîªÊîæ‰∏™2024Âπ¥11Êúà3Êó•‰ºäÊúóÁöÑË°óÊãçÔºå‰ºäÊñØÊ≥ïÁΩï„ÄÇüîªÁî±‰ºäÊúóÂçö‰∏ª Reza and Mahsa ÊãçÊëÑ„ÄÇ ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oeksnepoq/">
    
    
    
    
    
      
    
    üîªÊîæ‰∏™2024Âπ¥11Êúà3Êó•‰ºäÊúóÁöÑË°óÊãçÔºå‰ºäÊñØÊ≥ïÁΩï„ÄÇ<!-- raw HTML omitted -->üîªÁî±‰ºäÊúóÂçö‰∏ª Reza and Mahsa ÊãçÊëÑ„ÄÇ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.co">https://f.video.weibocdn.co</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKT56h5r">üîªËçâ#‰ªäÂπ¥ÁæéÂõΩÂ§ßÈÄâÂ∞ÜÊàêÂè≤‰∏äÊúÄË¥µ‰∏ÄÊ¨°##ÁæéÂõΩÂ§ßÈÄâËøΩË∏™# [ÂõæÁâá]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekt56h5r/">
    
    
    
    
    
      
    
    üîªËçâ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#‰ªäÂπ¥ÁæéÂõΩÂ§ßÈÄâÂ∞ÜÊàêÂè≤‰∏äÊúÄË¥µ‰∏ÄÊ¨°#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKxhzEJj">üîª„ÄäÁ∫ΩÁ∫¶Êó∂Êä•„ÄãÊäÄÊúØ‰∫∫ÂëòËÆ°ÂàíÂú®ÈÄâ‰∏æÊó•‰πãÂâç‰∏æË°åÁΩ¢ Â∑•„ÄÇüîªËπ≠ÁÉ≠Â∫¶ÊòØÂêßÔºü#‰ªäÂπ¥ÁæéÂõΩÂ§ßÈÄâÂ∞ÜÊàêÂè≤‰∏äÊúÄË¥µ‰∏ÄÊ¨°##ÁæéÂõΩÂ§ßÈÄâËøΩË∏™#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekxhzejj/">
    
    
    
    
    
      
    
    üîª„ÄäÁ∫ΩÁ∫¶Êó∂Êä•„ÄãÊäÄÊúØ‰∫∫ÂëòËÆ°ÂàíÂú®ÈÄâ‰∏æÊó•‰πãÂâç‰∏æË°åÁΩ¢ Â∑•„ÄÇ<!-- raw HTML omitted -->üîªËπ≠ÁÉ≠Â∫¶ÊòØÂêßÔºü<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#‰ªäÂπ¥ÁæéÂõΩÂ§ßÈÄâÂ∞ÜÊàêÂè≤‰∏äÊúÄË¥µ‰∏ÄÊ¨°#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEKz514c3">üîª‰∏Ä‰∏™‰øÑÂÜõÂ£´ÂÖµÂú®È£û FPVÔºå‰ªñÁöÑÊàòÂèãÂ∞±ÂÉèÁúãÁêÉËµõ‰∏ÄÊ†∑Ê¨¢Âëº„ÄÇüîªÁé∞ ‰ª£ Êàò ‰∫â„ÄÇüîªvia vk ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oekz514c3/">
    
    
    
    
    
      
    
    üîª‰∏Ä‰∏™‰øÑÂÜõÂ£´ÂÖµÂú®È£û FPVÔºå‰ªñÁöÑÊàòÂèãÂ∞±ÂÉèÁúãÁêÉËµõ‰∏ÄÊ†∑Ê¨¢Âëº„ÄÇ<!-- raw HTML omitted -->üîªÁé∞ ‰ª£ Êàò ‰∫â„ÄÇ<!-- raw HTML omitted -->üîªvia vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ÂåÖÂÆπ‰∏áÁâ©ÊÅíÊ≤≥Ê∞¥ÁöÑÂæÆÂçöËßÜÈ¢ë<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.c">https://f.video.weibocdn.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OEL5QucOc">üîª6ËøòÊòØ‰Ω†‰ª¨6#Âà´ÊéâËøõ8‰∏™ÁëûÂ£´Âç∑ÊÄé‰πàÂàÜÁöÑËØùÈ¢òÈô∑Èò±#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oel5qucoc/">
    
    
    
    
    
      
    
    üîª6ËøòÊòØ‰Ω†‰ª¨6<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#Âà´ÊéâËøõ8‰∏™ÁëûÂ£´Âç∑ÊÄé‰πàÂàÜÁöÑËØùÈ¢òÈô∑Èò±#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OEFLEqHUU">ËΩâÁôºÂæÆÂçö - ËΩ¨Âèë @‰πÉÊú®ÂùÇ46_‰∏≠Êùë‰∏Ω‰πÉ:&amp;ensp;‰∏≠Êùë‰∏Ω‰πÉÊó©‰∏äÂ•ΩÔºåÊàëÊòØ‰∏≠Êùë‰∏Ω‰πÉÔºÅÊàëÊöëÂÅáÂéªÊµ∑ÈáåÁé©ÂÑøÁöÑÊó∂ÂÄôÔºåË¢´Ê∞¥ÊØçÂà∫‰∫ÜÂ•ΩÂ§ö‰∏ãÔºåÂ§ßÂÆ∂‰∏ÄÂÆöË¶ÅÊ≥®ÊÑèÂïä #‰∏≠Êùë‰∏Ω‰πÉ# ‰πÉÊú®ÂùÇ46_...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oefleqhuu/">
    
    
    
    
    
      
    
    ËΩâÁôºÂæÆÂçö<!-- raw HTML omitted --><!-- raw HTML omitted --> - ËΩ¨Âèë <!-- raw HTML omitted -->@‰πÉÊú®ÂùÇ46_‰∏≠Êùë‰∏Ω‰πÉ<!-- raw HTML omitted -->:‚ÄÇ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰∏≠Êùë‰∏Ω‰πÉ<!-- raw HTML omitted --><!-- raw HTML omitted -->Êó©‰∏äÂ•ΩÔºåÊàëÊòØ‰∏≠Êùë‰∏Ω‰πÉÔºÅÊàëÊöëÂÅáÂéªÊµ∑ÈáåÁé©ÂÑøÁöÑÊó∂ÂÄôÔºåË¢´Ê∞¥ÊØçÂà∫‰∫ÜÂ•ΩÂ§ö‰∏ãÔºåÂ§ßÂÆ∂‰∏ÄÂÆöË¶ÅÊ≥®ÊÑèÂïä &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%253">https://m.weibo.cn/search?containerid=231522type%3</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OEKFehyeL">ÁÜ±ÂåÖÂ≠ê - ËΩ¨Âèë @È°∂Á≠ÜTEN‰Ωø:&amp;ensp;‰πÖ‰øùÂè≤Áª™Èáå#‰πÖ‰øùÂè≤Áª™ÈáåÊâãÊú∫Âçö# 2024.11.04 18:41„ÄåÂëúÂëºÂëº„Äç&lt;Âõæ&gt;‰ªäÂ§©‰ºº‰πéÊòØÂ•ΩÊé®‰πãÊó•*Ëøô‰∏™ÊúâÂèëËøáÊù•ÁùÄÂêóÔºÅÂõ†‰∏∫ÊòØËøôÊ†∑ÁöÑÊó•Â≠êÔºåÊâÄ‰ª•...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oekfehyel/">
    
    
    
    
    
      
    
    ÁÜ±ÂåÖÂ≠ê<!-- raw HTML omitted --><!-- raw HTML omitted --> - ËΩ¨Âèë <!-- raw HTML omitted -->@È°∂Á≠ÜTEN‰Ωø<!-- raw HTML omitted -->:‚ÄÇ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%253">https://m.weibo.cn/search?containerid=231522type%3</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEEQ6ElIQ">‰πÖ‰øùÂè≤Áª™Èáå#‰πÖ‰øùÂè≤Áª™ÈáåÊâãÊú∫Âçö# 2024.11.04 09:12„ÄåËØ∂ÂòøÂòø„ÄçÊó©‰∏äÂ•Ω‰ªäÂ§©‰∏ÄÊï¥Â§©‰πüÂä™ÂäõÂêßÊØèÂ§©ÈÉΩÊòØÂèóÂà∞ËÆ∏Â§öÂà∫ÊøÄÁöÑÊó•Â≠ê‰∫≤Ë∫´ÊÑüÂèóÂà∞ÊòØË¢´ÂÖ∂‰ªñ‰∫∫ÊîØÊåÅÁùÄÊâçËÉΩÁîüÊ¥ªÁöÑÊØèÂ§©ÔºåÂ§™...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oeeq6eliq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEF2683wZ">‰πÖ‰øùÂè≤Áª™Èáå „ÄåË¢´Êú™Êù•ÁöÑÊàëÊö¥ÂáªÔºÅ„ÄçEP.16 È°∂Á≠ÜTEN‰ΩøÁöÑÂæÆÂçöËßÜÈ¢ë</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oef2683wz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->„ÄåË¢´Êú™Êù•ÁöÑÊàëÊö¥ÂáªÔºÅ„ÄçEP.16 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/20">https://h5.sinaimg.cn/upload/20</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEIBszvAK">‰πÖ‰øùÂè≤Áª™Èáå#shiorigram# Âπ≥Á•êÂ•àÔºöÔºà‚ÄªÊèêÂèä‰πÖ‰øùÂè≤Áª™ÈáåÔºâü©µüíõË∑üÁª™ÈÖ±ÂéªÁúãËæ£Â¶πÂà∫ÂÆ¢ÁöÑÊó∂ÂÄôüî´‚ù§Ô∏èüî•Áù°ËßâÁöÑÁ¨®ËõãÂèØ‰ª•Âø´ÁÇπ‰∏äÊò†Âêó„ÉºÔºàÊòéÂπ¥Êò•Â≠£„ÄÇÔºâÔºà‚ÄªÊèêÂèäÁù°ËßâÁöÑ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oeibszvak/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEICUgyud">‰πÖ‰øùÂè≤Áª™Èáå#shiorigram# TaiÈÖ±Á≠â‰∏çÂèäÊòéÂπ¥Êò•Â≠£ÁöÑÂà∞Êù•Âë¢„ÄÅ„ÄÅ„ÄÅÊúâËÆ∏Â§öË∑üTaiÈÖ±„ÄÅÂíåÂâçËæàÁöÑÂõûÂøÜÁöÑÁÖßÁâá„ÄÇÔºà‚ÄªÊèêÂèäÂπ≥Á•êÂ•àÔºâÁîµÂΩ±„ÄéÁù°ËßâÁöÑÁ¨®Ëõã„ÄèÊòéÂπ¥Êò•Â§©‰∏äÊò†üå∏Ôºà‚ÄªÊèêÂèä...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oeicugyud/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shi &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEIK2di1G">‰πÖ‰øùÂè≤Áª™Èáå#shiorigram# ËΩªËΩªÈ£òËêΩÁöÑ10Êúà„ÄÇÂøÉËÑèË∑≥Âä®ÁöÑ11Êúà„ÄÇ [ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá][ÂõæÁâá]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oeik2di1g/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ËΩªËΩªÈ£òËêΩÁöÑ10Êúà„ÄÇ<!-- raw HTML omitted -->ÂøÉËÑèË∑≥Âä® &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEIWK0iI7">‰πÖ‰øùÂè≤Áª™Èáå#‰πÖ‰øùÂè≤Áª™ÈáåÊâãÊú∫Âçö# 2024.11.04 18:41„ÄåÂëúÂëºÂëº„Äç&lt;Âõæ&gt;‰ªäÂ§©‰ºº‰πéÊòØÂ•ΩÊé®‰πãÊó•*Ëøô‰∏™ÊúâÂèëËøáÊù•ÁùÄÂêóÔºÅÂõ†‰∏∫ÊòØËøôÊ†∑ÁöÑÊó•Â≠êÔºåÊâÄ‰ª•ÊâìÁÆóÂèëÂπ≥Êó∂‰∏ç‰ºöÂèëÁöÑ‰ΩÜÊòØÊúâÂèëËøáÊù•ÁùÄ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oeiwk0ii7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->‰πÖ‰øùÂè≤Áª™Èáå<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">¬© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

